Cholangiocarcinoma arising in Von Meyenburg complex associated with hepatocellular carcinoma in genetic haemochromatosis

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 2, 2000, Pages 233-237

  Blanc, Jean Frédéric ^a   Bernard, Pierre Henri ^a   Carles, Jacques ^a   Bail, Brigitte Le ^b,c   Balabaud, Charles ^a,c   Bioulac Sage, Paulette ^b,c  

^a HÔPITAL SAINT ANDRÉ   (France)

^b HÔPITAL PELLEGRIN   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cholangiocarcinoma; Haemochromatosis; Hepatocellular carcinoma; Reversibility of cirrhosis; Von Meyenburg complexes

Indexed keywords

ALPHA FETOPROTEIN; IRON; PROTHROMBIN;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CASE REPORT; GENETIC DISORDER; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER RESECTION; MALE; PHLEBOTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RELAPSING POLYCHONDRITIS; THROMBOCYTE COUNT;

EID: 0034105472     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012020-00016     Document Type: Article

References (15)

1. 1 Deugnier YM, Guyader D, Crantock L, Lopez JM, Turlin B, Yaouanq J, et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 1993; 104:228-234.
2. 2 Blanc J-F, Bernard P-H, De Lédinghen V, Le Bail B, Trimoulet P, Saric J, Bioulac-Sage P. Premalignant lesions of hepatocellular carcinoma in a non-cirrhotic, alcoholic patient with iron overload and normal transferrin saturation. J Hepatol 1999; 30:325-329.
3. 3 Yaziji N, Martin L, Hillon P, Favre JP, Henninger JF, Piard F. Cholangiocarcinome développé sur micro-hamartomes biliaires chez un malade atteint d'hémochromatose. Ann Pathol 1997; 17:346-349.
4. 4 Blumberg RS, Chopra S, Ibrahim R, Crawford J, Farraye FA, Zeldis JB, et al. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology 1988; 95:1399-1402.
5. 5 Zimmermann H, Reichen J, Zimmermann A, Sagesser H, Thenisch B, Hoflin F. Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat. Gastroenterology 1992; 103:579-589.
6. 6 Dufour JF, Delellis R, Kaplan MM. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997; 127:981-985.
7. 7 Deugnier Y, Turlin B, Loréal O. Iron and neoplasia. J Hepatol 1998; 28:21-25.
8. 8 Naccarato R, Farinati F. Hepatocellular carcinoma, alcohol and cirrhosis: fact and hypotheses. Dig Dis Sci 1991; 36:1137-1142.
9. 9 Yu MW, Gladek-Yarborough A, Chiamprasert S, Santella RM, Liaw YF, Chen CJ. Cytochrome P450 2E1 and glutahione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 1995; 109:1266-1273.
10. 10 Le Bail B, Bernard PH, Carles J, Balabaud C, Bioulac-Sage P. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol 1997; 27:835-842.
11. 11 Callea F, Sergi C, Fabbretti G, Brisigotti M, Cozzuto C, Medicina C. Precancerous lesions of the biliary tree. J Surg Oncol 1993; 3:131-133.
12. 12 Chen KT. Adenocarcinoma of the liver: association with congenital hepatic fibrosis and Caroli's disease. Arch Pathol Lab Med 1981; 105:294-295.
13. 13 Kowdley KV, Hassanein T, Kaur S, Farrell JF, Van Thiel DH, Sorrell MF, et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transpl Surg 1995; 1:237-241.
14. 14 Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Strarzl TEE. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998; 227:70-79.
15. 15 Harrison LE, Fong Y, Klimstra DS, Zee SY, Blurngart LH. Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 1998; 85:1068-1070.